| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/31/2026 | ±3.5% | +2.7% | over-priced |
| 05/01/2026 | ±3.1% | +0.5% | over-priced |
| 02/20/2026 | ±4.0% | +2.4% | over-priced |
| 10/31/2025 | ±3.6% | +2.7% | over-priced |
| 08/01/2025 | ±4.1% | -7.8% | under-priced |
| 04/25/2025 | ±3.5% | +0.3% | over-priced |
| 02/27/2025 | ±1.9% | -0.3% | over-priced |
| 11/01/2024 | ±1.2% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.71 | $9.2B | $559M |
| Q1 FY2026 | $0.38 | $7.2B | $125M |
| Q4 FY2025 | — | $7.1B | $-140M |
| Q3 FY2025 | $-2.77 | $7.7B | $-890M |
LYB (LYB) reports in 3 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 2.1% on average — the market has systematically over-priced LYB's earnings risk. Fundamentals into the print: EPS up 402.9% year-over-year, revenue up 19.8%. QuantLogix's live 5-factor engine currently reads LYB as a buy at 67/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →